Abstract Rosai-Dorfman disease (sinus histiocytosis with massive lymphadenopathy, SHML) is a rare, nonhereditary, benign histiocytic proliferative disorder, presenting as painless bilateral cervical lymphadenopathy, with systemic symptoms. Extra nodal manifestations have been reported in 28-43 % cases with rare ocular involvement. We report a case of a 57 year old female presenting with gradual progressive decrease of vision OU since 8 months associated with epistaxis. Fundus examination revealed established optic atrophy in right eye with features of chronic papilloedema in left eye suggestive of compressive lesion. CT of brain, paranasal sinuses confirmed the presence of homogenously enhancing mass in left ethmoid sinus, left sphenoid sinus extending into suprasellar region. The biopsy of this mass revealed extra nodal SHML with tissue sections being S100 and CD68 positive with emperipolesis noted. Here we describe this atypical ocular presentation of extra nodal SHML to highlight that this rare disease can manifest as an aggressive sight threatening entity, even in older age group.
Introduction
Rosai-Dorfman disease (RDD) is a rare histiocytic disorder initially described as a separate entity in 1969 by Rosai and Dorfman under the term sinus histiocytosis with massive lymphadenopathy (SHML) [1] . Rosai-Dorfman disease is a benign systemic histioproliferative disease characterized clinically by massive bilateral cervical lymphadenopathy, fever, leukocytosis, raised erythrocyte sedimentation rate, and pathologically, by hyperplastic lymph node sinuses containing large histiocytosis with intact phagocytosed lymphocytes (emperipolesis) [2] .
The causes of RDD are not fully understood, and treatment strategies can be different according to severity or vital organ involvement. Extra nodal involvement by RDD has been documented in 43 % of cases with the most frequent sites being skin, soft tissue, upper respiratory tract, multifocal bone, eye, and retro-orbital tissue with lymphadenopathy or as an isolated initial manifestation.
Extra nodal involvement has been reported in 28-43 % of the cases with the skin as the most commonly involved site. Ocular involvement is relatively rare (8.5 %), and mostly manifested as lymphoproliferation in the soft tissues of the orbit [3] .
Case Report
A 57 year old female came referred to the ophthalmic OPD from ENT services in view of gradual progressive loss of vision since 8-9 months. The patient had an episode of epistaxis 2-3 months back. There was history of associated floaters and gradual diminution of vision in both eyes, painless and progressive since 8-9 months. Left eye cataract surgery was done 3 years back with poor post & Eesha Shukla eesha3388@gmail.com operative vision. There was no perception of light in either of the eye. Right eye pupil was sluggishly reacting to light while the left eye pupil was circular, mid dilated, and not reacting to light. On slit lamp examination, the right eye showed immature cataract and the left eye was pseudophakic. A pendular nystagmus was noted on examination. Intra ocular pressure measured with applanation was 20 mm of hg in the right eye and 14 mm hg in the left eye. Gonioscopy showed all angles to be open in both eyes. Dilated 78D examination showed neurological cupping in both eyes (left more than right, with optic disc pallor being more than the cupping). Dilated ophthalmoscopy examination confirmed the diagnosis of bilateral optic atrophy (Fig. 1a, b) . Patient underwent further investigations and neuroimaging. CT scan of the brain, orbit and paranasal sinuses revealed an ill defined enhancing soft tissue mass; in left nasal cavity extending into the left maxillary sinus, ethmoidal, frontal and sphenoid sinus (3 9 4 cms) with bone destruction of wall of the sinuses. The same lesion showed continuity in suprasellar region (3.4 9 3.8 cms). Bilateral bony orbit and optic nerves were normal (Fig. 2a, b) .
Nasal mass biopsy was advised by ENT services and the tissue sent for histopathology evaluation. Characteristic features consistent with the diagnosis of Extra Nodal Rosai Dorfman Disease were found on immunohistochemistry.
Marked histiocytosis was present. Hematoxylin and eosin stain showed emperipolesis (lymphophagocytosis) (Fig. 3 ). Histiocytes were positive for S100 and CD68, which are histiocyte markers.
The salient features of this case were that the patient presented late for ophthalmic evaluation, owing to social reasons. Usually Rosai Dorfman Disease is self limiting, not requiring treatment, however in our case it caused sinus wall destruction with compressive optic atrophy. Size, extent, and location of tumor was such that it was in a precarious location.
Discussion
RDD is characterized by abnormal proliferation of histiocytes which are tissue macrophages belonging to the monocyte-macrophage lineage. Usually histiocytes are present in the lymph node sinuses i.e. the sub capsular region of a lymph node. Hence the term sinus histiocytosis, which usually presents with massive lymphadenopathy [4, 5] .
The current working hypothesis on pathogenesis of RDD is recruitment of bone marrow monocytes from peripheral blood into lymph nodal sinuses or extranodal sites and their transformation into the immunophenotypically distinct RDD histiocytes which demonstrate emperipolesis. Release of cytokines like TNF alpha from these cells is responsible for the genesis of fever and other systemic symptoms.
Amongst extra nodal manifestations of RDD, eye and adnexal involvement is seen in 11 % of patients and CNS involvement, as in our case is seen in only 7 % (Table 1) .
Ocular involvement is mostly seen in the form of orbital involvement, subconjunctival nodules, sub retinal exudates, or anterior uveitis [6] .
Immunohistochemistry markers and H&E staining are diagnostic investigations. They demonstrate histiocytes of RDD which are S100-positive. CD68, a marker for phagocytic histiocytes is also positive in histiocytes of RDD as is Alpha 1 antichymotrypsin. Emperipolesis (lymphophagocytosis) literally means intact cell within the cytoplasm of another cell. It is a distinguishing feature of the disease.
Surgical excision, radiotherapy, and chemotherapy along with systemic steroids are the available treatment modalities.
The ideal treatment for Rosai-Dorfman disease has not been established, owing to the rarity of the disease. Only about 50 % of patients with Rosai-Dorfman disease need some form of treatment [7] .
Radiotherapy and antimetabolite treatment have been considered in a few cases but the literature review does not suggest any conclusive role of these treatment modalities.
No randomized control trials have been done as the disease in itself is rare. A large literature review by Pulsoni et al. [5] concluded that clinical observation without treatment is advisable when possible. In the presence of vital organ compression and/or extra nodal localization with important clinical signs, surgical debulking may be necessary. Radiotherapy has shown limited efficacy, while chemotherapy is in general ineffective [8, 9] .
In conclusion, Rosai-Dorfman disease can present, even in an elderly age group, with features suggestive of compressive optic atrophy. This case highlights an unusual manifestation of a rare disease, diagnosed on ophthalmic evaluation. Usually considered benign, this disease can also manifest as an aggressive sight threatening entity. Liaising with other specialties is essential for a complete diagnosis and favorable patient outcomes.
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